World hepatitis day 2014
Hepatitis is a viral infection that causes acute and chronic disease, and sometimes death. World hepatitis day takes place each year on 28 July and the aim of this year’s World Health Organization’s campaign is to raise awareness of viral hepatitis. This is a group of infectious diseases known as Hepatitis A, B, C, D, and E.
NDM spoke to Paul Klenerman, Professor of Immunology in Experimental Medicine, about his research on Hepatitis C and the advances that are being made in treatment approaches.
Q: How big a problem is Hepatitis C infection?
Paul Klenerman: Hepatitis C infection is a real problem in the UK, affecting around a quarter of a million people. It is also a major problem globally, with estimates of around 170 million infected with Hepatitis C. Hepatitis B and Hepatitis C viruses together are thought to infect about half a billion, or 1 in 12, people around the world. Both viruses are leading causes of liver disease; often infection is silent for many years, but ultimately it can progress on to severe scarring of the liver (cirrhosis). This then brings with it the risk of liver failure and liver cancer. One of the problems with assessing the size of the problem is that many people are not diagnosed. These individuals then do not know about the risks of the disease or passing it on to others. One of the main aims of World Hepatitis Day is therefore to simply raise awareness about the problem of hepatitis infection.
Q: Why are some people able to clear the virus but others become chronically infected?

PK: Hepatitis C virus (HCV) is able typically to set up persistent infection - one reason is that it is able to vary its proteins and so continuously escape from immune responses. We often see patients in the clinic who were likely initially infected decades ago, perhaps after a single exposure to the virus. However, although HCV is very good at evading the immune system, some people are able to clear the virus after a brief period - this occurs in about 1 in 4 people overall. We know a few things that contribute to this. Your genetic background is very important. For example there are variations around a gene in the immune system (interferon-lambda) which have a big impact. This gene also affects the response to treatments so overall appears to be very important in clearing virus from the liver. Additionally, and this is what we have been mainly studying in Oxford, you can induce immune responses against HCV which can help clear it. Again, the type of immune responses you make depend on a set of genes (HLA type - the same genes that make up your tissue type used in matching transplants). Although the genetics are important, this doesn't account for everything. Recent studies have shown the strain of virus (or genotype) can have an effect too, and there are likely to be many other factors involved. However, since we know that having a very strong immune response of a particular kind (based on T cells) is linked with being able to clear the virus, the hope is that we can generate such responses using a vaccine. We have helped trial such vaccines at the Oxford University Hospitals and these are now in much bigger studies to see if they work effectively.
Q: Is it possible to tailor treatments to different groups of patients?
PK: Yes. At the moment, there are two main strains (genotypes) of HCV in the UK - type 1 and type 3. We have known for a while that we have to treat these different genotypes differently. It is possible to use the DNA tests described above to help with decision making. We can also see how the virus responds to treatment over time, to see how long it needs to be treated for, which is typically around six months. (However, at the moment, treatments are just changing from the older types, - which are based on interferon injections - to newer types based on tablets, which directly interfere with the virus and are better tolerated. These new drugs can be very quick and effective, curing more than 90% of people (the current treatments are around 60-70% effective). However, it will be very important to make sure we use these new treatments wisely. For example, depending on the exact drug used, knowing the exact sequence of the virus might be helpful in avoiding resistance. It is still very early days, though and only a few of the very sickest patients who have severe liver failure have been treated so far in the UK. The OUH is an important hub for studies of how best to use these drugs through a national programme called STOP-HCV (led by Dr Ellie Barnes). We are aiming through this programme to design strategies that allow tailored treatments, and help the roll-out of really effective therapy in the coming years. Hopefully we will have cured many patients this way by World Hepatitis Day 2015.
- Institutes, centres & units
- NDM Strategic
- Contact
- Public Involvement
-
News
- Using management thinking to fight the superbug crisis
- Getting rid of malaria possible, if we try something new, say experts
- Success for NDM project awarded Public Engagement Seed Funding
- Flu vaccine spinout secures a further £20m in funding
- Global health needs demand new approach to drug discovery
- Building international partnerships to tackle disease
- Nepali pilgrims to Gosaikunda video
- China Vice Premier in Oxford for signing of research collaboration
- Largest genetic study of mosquitoes reveals spread of insecticide resistance across Africa
- Researchers attack Mekong malaria superbug on multiple fronts
- Kevin Marsh Wins 2017 Drexel Prize in Infectious Disease
- Prof Simon Leedham wins CRUK Prize
- Oxford-Mahidol collaboration shortlisted for Newton Prize
- BioBeat unveils 2017’s 50 Movers and Shakers
- Study raises possibility of vaccines against allergies and Alzheimer’s
- Celebrating Oxfordshire brightest science stars
- New structural insights accelerate drug discovery in the ubiquitin system for cancer therapy
- National Academy of Medicine elects Nick White as international member
- New collaboration to tackle superbugs
- 115 years of malaria in Africa
- Oxford and the mosquito
- World-first trial for universal flu vaccine
- New typhoid vaccine offers hope of protection for children
- Prof Emily Chan wins the 2017 UGC Teaching Award
- The Medical Research Foundation to fund first national PhD Training Programme to tackle antimicrobial resistance
- Superbug’s spread to Vietnam threatens malaria control
- New NDM Professors
- Establishing the Africa Oxford Initiative
- Combining cultures
- Experts urge rethink of ‘outdated’ asthma categorisation
- International research network nominated for ‘Oscar of higher education’
- Oxford University claims top world ranking for second year
- Bash the Bug! Winner of 2017 NIHR Let’s Get Digital competition
- Scientists discover unknown virus in ‘throwaway’ DNA
- Improved home designs may fight malaria in Africa
- Antibodies may reveal timing of previous influenza infection
- Discovery Award to decode TB DNA
- Is it time to drop the ‘complete the course’ message for antibiotics?
- World Hepatitis Day
- Call for Abstract MVVR5 2017
- Breaking boundaries in our DNA
- Quick test can predict anaemia in malaria patients treated with artemisinins
- New Year's Honours 2018
- What's behind the sudden rise in measles deaths in Europe?
- Cancer hijacks natural cell process to survive
- Mahidol begins Asia’s first study of RTS,S malaria vaccine
- Oxford one of six sites to receive funding for health data science
- Five surprising things DNA has revealed about our ancestors
- OUMNH Exhibition based on centre research
- Could aspirin be used to treat tuberculous meningitis?
- ALS Reproducible Antibody Platform launched
- Cultural barriers to tackling the superbug crisis
- ALERRT epidemic research network launched in sub-Saharan Africa
- Making malaria visible
- Women in STM
- Female body shape gene may increase risk of type 2 diabetes
- The town that breeds resistance to Malaria drugs
- Can you cure HIV?
- Professor Dominic Kwiatkowski joins the Fellowship of the Royal Society
- Prof Vincenzo Cerundolo elected Fellow of the Royal Society
- NDM Researchers elected as Fellows of the Academy of Medical Science
- Using management thinking to fight the superbug crisis
- FORMA Therapeutics and the University of Oxford Announce Multi-Year Cross-Border Collaboration
- HIV researchers create Chelsea garden to raise awareness of disease stigma
- China Vice Premier and Minster of National Health Commission visit to CTI Beijing
- Oxford overtakes Cambridge for first time in QS world rankings
- New age-based regimen for single low-dose primaquine to block malaria transmission
- Rosalind Franklin Institute will 'transform' life sciences research through disruptive technologies
- Big Data Institute wins a 2018 RIBA South Award
- NDM Researcher gets £1m boost to study immunology of asthma
- Professor Rose McGready awarded Alumni Award for Service to Humanity
- Researchers explore malaria vaccines and antibiotic resistance at RS Summer Science Exhibition
- Trial of ‘kick and kill’ approach to HIV cure leaves puzzles to be solved
- NDM Researcher recognised for major contribution in clinical sciences
- ASHG Honours Professor Cecilia Lindgren with Mentorship Award
- New NDM Professors
- Prof Helen McShane appointed as new Director of Oxford Biomedical Research Centre
- Detailed map of colon cells in health and disease
- UK-led study marks shift towards genetic era in tackling TB
- Tales of treatment, of modernity and tradition, and of global health crisis
- Faith Osier TED talk
- 'Tantalising and exciting’: UK Biobank genetics opens the door to a new era of health research
- Oxford secures £17.5 million to lead national programmes in AI to improve healthcare
- New grant to study the role of immune cells in lung regeneration
- Dr Ross Chapman welcomed as EMBO Young Investigator
- New vaccines centre to protect UK from pandemic threats
- Professor Sir David Weatherall: 1933-2018
- Congratulations to Jeremy Farrar, knighted in the New Year's Honours 2019
- Watch Prof Peter Donnelly speak at Royal Society AI event
- NDM's Translational Gastroenterology Unit awarded a CRUK Primer grant of £100,000
- ISARIC awarded £4.5 million to tackle the global threat of epidemic infectious diseases
- Tracking resistance results presented at Westminster
- The battle within- new animation on the immune system
- Vaccine developed to treat osteoarthritic pain
- World Malaria Day 2019
- Faces of malaria
- Mads Gyrd-Hansen awarded Wellcome Trust Senior Research Fellowship renewal
- NDM Researchers elected Fellows of the Academy of Medical Sciences
- Oxford academics recognised in 2019 Queen’s Birthday Honours
- Ross Chapman awarded 2019 Lister Prize
- New maps could show how to beat malaria
- Vice-Chancellor’s Choice Award for Public Engagement with Research
- New malaria parasite mutations cause alarming antimalarial drug failures in Southeast Asia
- New NDM Professors
- The RECOVERY Trial has recruited 1000 patients in 15 days
- Controlling coronavirus transmission using a mobile app to trace close proximity contacts
- Digital contact tracing can slow or even stop coronavirus transmission and ease us out of lockdown
- Oxford's COVID-19 research receives government funding
- First patients enrolled in new clinical trial of possible COVID-19 treatments
- Covid-19: how effective is social distancing?
- Infectious disease experts provide evidence for a coronavirus mobile app for instant contact tracing
- Sir Peter Ratcliffe on BBC Radio 4 - The Life Scientific
- Wellcome Investigator Awards
- International research consortium activates clinical study for novel coronavirus in England and Scotland
- Professor Vincenzo Cerundolo FRS 1959-2020
- Oxford University awarded €56 million in European Research Council funding
- Oxford named best for medicine for ninth consecutive year
- NDM DPhil Graduate Student Prizes 2019
- Modelling research aims to inform new WHO roadmap for neglected tropical diseases
- Woman of the Future award for Science
- Obesity now linked to broader range of leading killers, with women and men showing different patterns of risk
- Medical Sciences and climate breakdown: time to move beyond evidence
- Oxford Tropical Medicine awarded two RSTMH medals
- Oxford ranked world’s best university for fourth year running
- Landmark partnership announced for development of COVID-19 vaccine
- Chan Zuckerberg Initiative awards funding to Oxford team to support inflammation research
- Oxford University Coronavirus Research Webinar
- New study reveals Oxford coronavirus vaccine produces strong immune response
- The Duke of Cambridge visits Oxford Vaccine Centre
- The Ludwig Institute for Cancer Research welcomes cancer epigenetics researcher Yang Shi
- New NDM titles awarded
- Future of Oxford professorship in vaccinology secured with £3.5 million gift
- Oxford study suggests notable decline in coronavirus cases and R rate on Isle of Wight after launch of the test and trace programme
- Dave Stuart awarded The Gabor Medal 2020
- Latest version of COVID-19 contact tracing app ready for testing on the Isle of Wight and Newham, London
- Collaboration with Magdalen College outreach to run remote work experience
- Persistent immune memory of COVID-19 found in recovered patient T cells
- New research shows tracing apps can save lives at all levels of uptake
- Evaluation of LamPORE rapid tests for Covid-19 show high levels of diagnostic sensitivity
- Comparison of five tests used to detect COVID-19 antibodies shows Siemens and Oxford assays met regulatory targets
- Oxford’s OpenABM-Covid19 mathematical model helps to control the coronavirus epidemic
- Oxford’s OpenABM-Covid19 mathematical model helps to control the coronavirus epidemic
- The University of Oxford and King Abdulaziz University (KAU) have partnered to create a new Centre for Artificial Intelligence and Precision Medicine.
- Professor Sarah Walker, a Professor of Medical Statistics and Epidemiology in NDM and the Oxford BRC’s Co-theme Lead for Antimicrobial Resistance and Modernising Microbiology, is to receive an OBE.
- Simon Leedham appointed as Professor of Molecular and Population Genetics
- Two vital research programmes taking place at the university of Oxford may hold the key to understanding the immunity of recovered Covid-19 patients.
- New partnership with The Alan Turing Institute and Royal Statistical Society to support Joint Biosecurity Centre COVID-19 response
- NDM’s Jenner Institute appoints first Bvlgari Scholars
- NDM New Professors
- Trials of Oxford coronavirus vaccine begin in Kenya
- Oxford ramps up COVID-19 testing capability
- Oxford’s vaccine research and development boosted by donation from Wafic Saïd
- Oxfordshire Young Scientists of the Year 2020
- Oxford University breakthrough on global COVID-19 vaccine
- First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy
- Statement from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on azithromycin, 14 December 2020
- National COVID-19 Infections Survey reveals changes to pandemic over time
- Professor Susie Dunachie awarded flagship NIHR career development award
- Oxford University welcomes UK regulatory emergency use authorisation of coronavirus vaccine
- Professor Sir Dave Stuart, FRS FMedSci knighted in New Year's Honours
- Work for us